Evidence map›Paper›PMID 31881176›Full record

ArticleToxicology and applied pharmacology2020

A toxicogenomic approach for the risk assessment of the food contaminant acetamide.

Rance Nault, Bryan Bals, Farzaneh Teymouri, Michael B Black, Melvin E Andersen, Patrick D McMullen, Seetha Krishnan, Nagesh Kuravadi, Neetha Paul, Santhosh Kumar and 9 more

Open access · hybridAbstract read
In one paragraph

Article in Toxicology and applied pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 21 citations in OpenAlex.

  1. Application of a metabolic network-based graph neural network for the identification of toxicant-induced perturbations.Toxicological sciences : an official journal of the Society of Toxicology · 2025
    Article
  2. Investigating the dependency of in vitro benchmark concentrations on exposure time in transcriptomics experiments.Toxicology in vitro : an international journal published in association with BIBRA · 2024
    Article
  3. State of the Art of Genomic Technology in Toxicology: A Review.International journal of molecular sciences · 2023
    Review
  4. Review
  5. Article
  6. A Set of Six Gene Expression Biomarkers Identify Rat Liver Tumorigens in Short-term Assays.Toxicological sciences : an official journal of the Society of Toxicology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 2 countries.

Rance NaultInstitute for Integrative Toxicology, Biochemistry & Molecular Biology, Michigan State University, East Lansing, MI, United States of America.
Bryan BalsMichigan Biotechnology Institute, Lansing, MI, USA.
Farzaneh TeymouriMichigan Biotechnology Institute, Lansing, MI, USA.
Michael B BlackScitoVation, Durham, NC, USA.
Melvin E AndersenScitoVation, Durham, NC, USA.
Patrick D McMullenScitoVation, Durham, NC, USA.
Seetha KrishnanSyngene International, Bengaluru, India.
Nagesh KuravadiSyngene International, Bengaluru, India.
Neetha PaulSyngene International, Bengaluru, India.
Santhosh KumarEurofins Advinus, Bengaluru, India.
Kamala KannanEurofins Advinus, Bengaluru, India.
K C JayachandraEurofins Advinus, Bengaluru, India.
Lakshmanan AlagappanEurofins Advinus, Bengaluru, India.
Bhavesh Dhirajlal PatelEurofins Advinus, Bengaluru, India.
Kenneth T Bogenktbogen.com, Silver Spring, MD, USA.
Bhaskar B GollapudiExponent, Alexandria, VA, USA.
James E KlaunigIndiana University Bloomington, Bloomington, IN, USA.
Tim R ZacharewskiInstitute for Integrative Toxicology, Biochemistry & Molecular Biology, Michigan State University, East Lansing, MI, United States of America.
Venkataraman BringiChemical Engineering & Materials Science, Michigan State University, East Lansing, MI, USA. Electronic address: bringi@msu.edu.
Michigan State University · USSyngene International (India) · INBiotechnology Institute · USExponent (United States) · USIndiana University Bloomington · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acetamide (CAS 60-35-5) is detected in common foods. Chronic rodent bioassays led to its classification as a group 2B possible human carcinogen due to the induction of liver tumors in rats. We used a toxicogenomics approach in Wistar rats gavaged daily for 7 or 28 days at doses of 300 to 1500 mg/kg/day (mkd) to determine a point of departure (POD) and investigate its mode of action (MoA). Ki67 labeling was increased at doses ≥750 mkd up to 3.3-fold representing the most sensitive apical endpoint. Differential gene expression analysis by RNA-Seq identified 1110 and 1814 differentially expressed genes in male and female rats, respectively, following 28 days of treatment. Down-regulated genes were associated with lipid metabolism while up-regulated genes included cell signaling, immune response, and cell cycle functions. Benchmark dose (BMD) modeling of the Ki67 labeling index determined the BMD

Indexed as

Food ContaminationModels, BiologicalAcetamidesAnimalsCarcinogenesisCarcinogensCell CycleCell ProliferationComputer SimulationDose-Response Relationship, DrugDown-RegulationFemaleGene Expression Regulation, NeoplasticHumansImmunityKi-67 AntigenacetamideAcetamidesCarcinogensKi-67 AntigenAcetamideCancerLiverRisk assessmentToxicogenomics

Identifiers

PMID31881176
PMCPMC7014822
OpenAlexW2998455760

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.